Literature DB >> 14733032

Diabetes mellitus related morbidity, risk of hospitalization and disability.

Abdelouahed Naslafkih1, François Sestier.   

Abstract

OBJECTIVE: To investigate the rates of complications, hospitalizations and disabilities attributable to type 1 and type 2 diabetes mellitus (DM) combined, unless otherwise noted.
METHODOLOGY: Risk assessment of DM-related morbidity, hospitalizations and disabilities using data from the medical literature and health statistics on the population. Calculation of morbidity, hospitalization, and disability ratios (MbR, HR, DR) will allow comparison of observed rates in people with DM to those reported in the nondiabetic population.
RESULTS: MbRs vary according to the morbid condition studied: approximately 300% at age 45-64 years for ischemic heart disease, 533% for coronary heart disease or stroke, 226% to 388% for chronic heart failure, 560% for peripheral vascular disease, 380% for neuropathy at age 35-74 years, 890% to 2225% for lower limb amputations, 1458% to 3287% for end-stage renal disease. For ocular complications: cataracts, 165% to 232%; glaucoma 140% to 330%; trouble seeing, 180% to 231%; blindness at age > or = 65 years, 517%. Higher values are noted at younger ages. HR: 200% to 409%. DR: 217% to 328%.
CONCLUSION: Among diseases, DM is one of the leading and growing causes of hospital admission and disability. Precise risk assessment of morbidity is essential for realistic underwriting of health and disability insurance.

Entities:  

Mesh:

Year:  2003        PMID: 14733032

Source DB:  PubMed          Journal:  J Insur Med        ISSN: 0743-6661


  9 in total

1.  [Prognostic value of cardiovascular MRI in diabetics].

Authors:  C L Schlett; R C Bertheau; H-U Kauczor; S Weckbach
Journal:  Radiologe       Date:  2015-04       Impact factor: 0.635

2.  Whole-Body MR Imaging Including Angiography: Predicting Recurrent Events in Diabetics.

Authors:  Robert C Bertheau; Fabian Bamberg; Elena Lochner; Hannes M Findeisen; Klaus G Parhofer; Hans-Ulrich Kauczor; Stefan O Schoenberg; Sabine Weckbach; Christopher L Schlett
Journal:  Eur Radiol       Date:  2015-08-25       Impact factor: 5.315

3.  Complications of Diabetes 2016.

Authors:  Konstantinos Papatheodorou; Nikolaos Papanas; Maciej Banach; Dimitrios Papazoglou; Michael Edmonds
Journal:  J Diabetes Res       Date:  2016-10-16       Impact factor: 4.011

4.  Using Routine Data to Categorize Poor Control Diabetic Patients: An Application of Cluster Analysis Technique.

Authors:  Farid Abolhassani Shahreza; Narjes Hazar
Journal:  Iran J Public Health       Date:  2017-01       Impact factor: 1.429

5.  The Effect of Diabetes Self-Management Education on Hba1c Level and Fasting Blood Sugar in Type 2 Diabetes Mellitus Patients in Primary Health Care in Binjai City of North Sumatera, Indonesia.

Authors:  Maya Savira; Rina Amelia
Journal:  Open Access Maced J Med Sci       Date:  2018-04-12

Review 6.  Baduanjin Exercise for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Junmao Wen; Tong Lin; Yinhe Cai; Qianying Chen; Yuexuan Chen; Yueyi Ren; Senhui Weng; Boqing Wang; Shuliang Ji; Wei Wu
Journal:  Evid Based Complement Alternat Med       Date:  2017-10-19       Impact factor: 2.629

7.  Serum Anti-Apo B Antibody Level as Residual CVD Marker in DM Patients under Statin Treatment.

Authors:  Hiroyasu Yamamoto; Mari Kawamura; Ikoi Kochi; Minami Imai; Yukie Murata; Toshinobu Suzuki; Yingchao Chen; Kunihiko Hashimoto; Shinji Kihara
Journal:  J Atheroscler Thromb       Date:  2019-03-14       Impact factor: 4.928

Review 8.  Protective effects of physical activity against health risks associated with type 1 diabetes: "Health benefits outweigh the risks".

Authors:  Addisu Dabi Wake
Journal:  World J Diabetes       Date:  2022-03-15

9.  Differences in U.S. Rural-Urban Trends in Diabetes ABCS, 1999-2018.

Authors:  Carla I Mercado; Kai McKeever Bullard; Edward W Gregg; Mohammed K Ali; Sharon H Saydah; Giuseppina Imperatore
Journal:  Diabetes Care       Date:  2021-06-14       Impact factor: 17.152

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.